CXCR3 inhibitors for therapeutic interventions: current status and perspectives
CXC chemokine receptor 3 (CXCR3) is a G protein-coupled chemokine receptor that plays a key role in regulating immune responses and is involved in various pathological processes, particularly in tumor development and inflammatory diseases, making it a novel target for clinical therapy. The expressio...
Saved in:
| Main Authors: | Rongrong Huo, Yu Jiang, Li Zhang, Shufang Du, Dan Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1556196/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CXCR4 and CXCR6 dually limit T cell entry into the polyomavirus-infected brain
by: Kalynn M. Alexander, et al.
Published: (2025-06-01) -
Combined treatment with CDK4/6, CDK2, and CXCR1/2 inhibitors effectively halts the growth of BRAF wild-type melanoma tumors
by: Jinming Yang, et al.
Published: (2025-08-01) -
Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models
by: Lucas A. Horn, et al.
Published: (2024-12-01) -
The metastatic role of the CXCL10-CXCR3 axis and its therapeutic potential in osteosarcoma
by: Benjamin B. Gyau, et al.
Published: (2025-06-01) -
A1, an innovative fluorinated CXCR4 inhibitor, redefines the therapeutic landscape in colorectal cancer
by: Hossein Khorramdelazad, et al.
Published: (2025-01-01)